share_log

Galectin Therapeutics(GALT.US) 10% Shareholder Sells US$76,500 in Common Stock

moomoo News ·  Apr 25 12:18

$Galectin Therapeutics (GALT.US)$ 10% Shareholder CZIRR JAMES C sold 25,000 shares of common stock on Apr 22, 23, 2024 at an average price of $3.06 for a total value of $76,500.

1714061929068427258.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment